Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 1, 2011-03 ,pp. : 1-5

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics: Has the Time Come for Pharmacists to Embrace and Implement the Science?

By Beier Manju   Panchapagesan Madhumitha   Carman Ladd  

The Consultant Pharmacist, Vol. 28, Iss. 11, 2013-11 ,pp. : 696-711

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 225-230

Bentham Science Publishers

Access to resources Recommend Favorite

Individual bioequivalence-has its time come?

By Endrenyi L.   Midha K.K.  

European Journal of Pharmaceutical Sciences, Vol. 6, Iss. 4, 1998-10 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Predictive Molecular Markers: Has the Time Come for Routine Use in Lung Cancer?

By Davies Angela M.   Mack Philip C.   Lara Primo N.   Lau Derick H.   Danenberg Kathleen   Gumerlock Paul H.   Gandara David R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 2, 2004-03 ,pp. : 125-131

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite